MedPath

Exploratory Study of 3D Printed Biodegradable Cervical Interbody Fusion Cage

Not Applicable
Conditions
Symptomatic Cervical Disc Disease
Interventions
Device: 3D printed biodegradable cervical fusion cage
Device: PEEK cage
Registration Number
NCT04167878
Lead Sponsor
Xijing Hospital
Brief Summary

A small sample, single center, non-randomized, noninferiority clinical trial to evaluate the safety and effectiveness of 3D printed biodegradable cervical interbody fusion cage in anterior cervical discectomy and fusion (ACDF) for treating patients with a symptomatic degenerative cervical disc disease at one level from C2/C4 to C7/T1.

Detailed Description

The study will evaluate if 3D printed biodegradable cervical interbody fusion cage is non-inferior to poly-ether-ether-ketone (PEEK) cage in single-level ACDF with the use of local autologous bone. 3D printed biodegradable cervical interbody fusion cage is a restorable cervical interbody cage for the treatment of fusion, following discectomy, of the cervical spine from C2/C4 disc space to the C7/T1 disc space. The material used to prepare the implant is a mixture of polycaprolactone (PCL) and tricalcium phosphate (TCP), which is called PCL-TCP. The implant has proper strength and connective porosity. The PCL-TCP cage is intended to be used with a supplemental fixation system.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  1. Skeletally mature patients aged between 25 and 85 years (inclusive);
  2. Symptomatic cervical disc disease (SCDD) in the vertebral level between C2/C3 to C7/T1, correlated with radiculopathy or myelopathy;
  3. Radiographic confirmation (by CT, MRI, x-ray, etc.) of any of the following: herniated nucleus pulposus, spondylosis or loss of disc height;
  4. Requires only one cervical vertebral level to be surgically treated;
  5. Failed at least 12 weeks of conservative treatment;
  6. Patient must understand and sign the Informed Consent document that has been approved by the Ethics committee;
  7. No significant restrictions showed by the pre-surgical routine test and examination.
Exclusion Criteria
  1. Skeletally immature patients;
  2. Prior radiation history at anterior cervical area;
  3. Prior surgery at the level to be treated;
  4. More than one vertebral level requiring treatment, confirmed radiologically by X-ray, CT, or MRI
  5. Complication of ossification of the ligamentum flavum, and Ossification of the posterior longitudinal ligament;
  6. Clinically compromised vertebral bodies at the affected level(s) due to trauma or tuberculosis
  7. Severe osteoporosis;
  8. Active systemic or local infection;
  9. Participation in other investigational device or drug clinical trials within 3 months of surgery;
  10. Other patients whom the investigator believe not appropriate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ACDF with 3D printed biodegradable cervical fusion cage3D printed biodegradable cervical fusion cageA resorbable cervical interbody cage made of PCL-TCP.
ACDF with PEEK cagePEEK cageA structural PEEK cage with autologous bone.
Primary Outcome Measures
NameTimeMethod
Radiologic evaluation12 months

Radiologic fusion assessed by roentgenographic examination or CT scan

Secondary Outcome Measures
NameTimeMethod
Japanese Orthopaedic Association Scores (JOA scores)12 months

The whole name is Japanese Orthopaedic Association Scores for Assessment of Cervical spondylosis, the range of JOA is 0-17 and the full score is 17 to represent a normal function.

Measurement of Pain: Visual Analog Scale (VAS)12 months

The whole name is Visual Analog Scale which is ranged from 0-10, with 0 being the least and 10 being the worst pain experienced.

© Copyright 2025. All Rights Reserved by MedPath